echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Int J Cancer: Does the number of pigmented moles correlate with cancer risk?

    Int J Cancer: Does the number of pigmented moles correlate with cancer risk?

    • Last Update: 2022-04-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Melanocytic nevi are benign skin tumors composed of localized overgrowths of melanin-forming cells
    .


    The tendency for moles to develop is genetically determined, although childhood sun exposure clearly plays a role


    Several large cohort studies have reported positive associations between higher mole counts and cancers including breast and thyroid
    .


    A recent study found an overall association between mole number and medical cancer (HR for 15 or more moles vs.


    Despite hypotheses linking moles and other cancers, whether the association between moles and cancer reported in observational studies represents a true relationship, or is due to factors associated with mole count and cancer (eg, clinical surveillance) due to bias or confusion remains unclear
    .


    Genome-wide association studies have successfully identified numerous genomic regions, including variants in CDKN2A and phospholipase A2 group VI (PLA2G6)


    We calculated polygenic risk scores (PRs) for mole counts using individual-level data from the UK Biobank (n=394306) and the QSkin cohort (n=17427)
    .


    Logistic regression analysis was performed on the effects of age, sex, and the top five principal components, evaluating the association between moles, PR, and each tumor site


    Table 1 Number of cancer cases and their prevalence in the UK Biobank and QSkin cohorts

     

    Figure 1 Association between genetically predicted mole counts and individual or overall cancer risk, according to the quartile of mole count, polygenic risk score (PRS), using individual-level data from the UK Biobank
    .


    Any cancer excludes skin cancer; blood diseases includes leukemia and lymphoma; head and neck excludes lip cancer; basal cell carcinoma; squamous cell carcinoma, squamous cell carcinoma of the skin

    Figure 2 Association of genetically predicted mole counts with individual or overall cancer risk according to mole count quartile polygenic risk score (PRS) using individual-level data from the QSkin cohort
    .


    Any cancer excludes skin cancer; blood cancer includes leukemia and lymphoma; head and neck excludes lip cancer; BCC, basal cell carcinoma; SCC, squamous cell carcinoma of the skin

    In conclusion, we found a significant association between high genetic risk of moles and skin cancer, but no evidence of an association between high genetic risk moles and cancer risk
    .


    We reasoned that the association between freckles count and cancer reported in earlier observational studies is unlikely to be causal


    Source: Dusingize JC, Law MH, Pandeya N, Genetically determined cutaneous nevi and risk of cancer.


    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.